A Message to Our Customers and Partners Regarding COVID-19

Dernières informations

Nanopharm to Host Webinar on April 21st Discussing In-Vitro Dissolution Testing for Orally-Inhaled Drug Products En savoir plus
Aptar Requests U.S. FDA Emergency Use Authorization for N95 Filtering Facepiece Respirator Decontamination with ActivShieldTM En savoir plus
Aptar an Essential Partner to the Food, Healthcare and Consumer Products Industries During COVID-19 Pandemic En savoir plus
Voir toutes les informations